Dendritic cells expressing a combined PADREMUC4-derived polyepitope DNA vaccine induce multiple cytotoxic T-cell responses

Cancer Biotherapy and Radiopharmaceuticals

Volumn 23, Issue 1, 2008, Pages 121-128

  Wei, Jishu ^a   Gao, Wentao ^a   Wu, Junli ^a   Meng, Kai ^a   Zhang, Jingjing ^a   Chen, Jianmin ^a   Miao, Yi ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cytotoxic T lymphocyte; Dendritic cells; Mucin4; PADRE; Tumor vaccine

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; DENDRITIC CELL VACCINE; DNA VACCINE; EPITOPE; GREEN FLUORESCENT PROTEIN; HLA A1 ANTIGEN; HLA A2 ANTIGEN; HLA DR ANTIGEN; MUCIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CELL STRAIN COS7; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; GENE STRUCTURE; GENETIC TRANSFECTION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; EPITOPES; GENETIC ENGINEERING; HUMANS; INTERFERON TYPE II; MALARIA VACCINES; MOLECULAR SEQUENCE DATA; MUCINS; NEOPLASMS; PHENOTYPE; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; VACCINES, DNA;

EID: 39749146393     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2007.0427     Document Type: Article

References (30)

1. Porchet N, Cong N, Dufosse J, et al. Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem Biophys Res Commun 1991;175:414.
2. Andrianifahanana M, Moniaux N, Schmied B, et al. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: A potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res 2001;7:4033.
3. Smith S. The polyepitope approach to DNA vaccination. Curr Opin Mol Ther 1999;1:10.
4. Pasquini S, Xiang Z, Wang Y, et al. Cytokines and costimulatory molecules as genetic adjuvants. Immunol Cell Biol 1997;75:397.
5. Hodge J, Greiner J, Tsang K, et al. Costimulatory molecules as adjuvants for immunotherapy. Front Biosci 2006;11:788.
6. Brossart P, Heinrich K, Stuhler G, et al. Identification of HLA-A2-Restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies. Blood 1999;93:4309.
7. Heiser A, Dahm P, Yancey D, et al. Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. J Immunol 2000;164:5508.
8. Pan Y, Zhang J, Zhou L, et al. In vitro antitumor immune response induced by dendritic cells transfected with EBV-LMP2 recombinant adenovirus. Biochem Biophys Res Commun 2006;347:551.
9. Price-Schiavi S, Perez A, Barco R, et al. Cloning and characterization of the 5′ flanking region of the sialomucin complex/rat MUC4 gene: Promoter activity in cultured cells. Biochem J 2000;349:641.
10. Kwon K, Ro J, Singhal N, et al. MUC4 expression in non-small-cell lung carcinomas: Relationship to tumor histology and patient survival. Arch Pathol Lab Med 2007;131:593.
11. Chauhan S, Singh A, Ruiz F, et al. Aberrant expression of MUC4 in ovarian carcinoma: Diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod Pathol 2006;19:1386.
12. Alos L, Lujan B, Castillo M, et al. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6, and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol 2005;29:806.
13. Yamano T, Kaneda Y, Hiramatsu SH, et al. Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21. Cancer Gene Ther 2007;14:451.
14. Sun W, Qian H, Zhang X, et al. Induction of protective and therapeutic antitumour immunity using a novel tumour-associated antigen-specific DNA vaccine. Immunol Cell Biol 2006;84:440.
15. Takamura S, Matsuo K, Takebe Y, et al. Ag85B of mycobacteria elicits effective CTL responses through activation of robust Th1 immunity as a novel adjuvant in DNA vaccine. J Immunol 2005;175:2541.
16. Tsuji T, Yasukawa M, Matsuzaki J, et al. Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes. Blood 2005;106:470.
17. Alexander J, Sidney J, Southwood S, et al. Development of high-potency universal DR-restricted helper epitopes by modification of high-affinity DR-blocking peptides. Immunity 1994;1:751.
18. Ishioka G, Fikes J, Hermanson G, et al. Utilization of MHC class I transgenic mice for development of mini-gene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J Immunol 1999;162:3915.
19. Hung C, Tsai Y, He L, et al. DNA vaccines encoding Ii-PADRE generates potent PADRE-specific CD4 (+) T-cell immune responses and enhances vaccine potency. Mol Ther 2007;15:1211.
20. Heemskerk M, Hooijberg E, Ruizendaal J, et al. Enrichment of an antigen-specific T-cell response by retrovirally transduced human dendritic cells. Cell Immunol 1999;195:10.
21. Velders M, Weijzen S, Eiben G, et al. Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine. J Immunol 2001;166:5366.
22. Huebener N, Lange B, Lemmel C, et al. Vaccination with minigenes encoding for novel "self" antigens are effective in DNA-vaccination against neuroblastoma. Cancer Lett 2003;197:211.
23. Livingston BD, Newman M, Crimi C, et al. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine 2001;19:4652.
24. Xu J, Yao K, Yu C. Antitumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T-lymphocytes induced by dendritic cells. Auris Nasus Larynx 2006;33:441.
25. Chen L, Liang G, Tang X, et al. In vitro antitumor immune response induced by dendritic cells transfected with hTERT recombinant adenovirus. Biochem Biophys Res Commun 2006;351:927.
26. Oha S, Kimb C, Park M, et al. Dendritic cells transduced with recombinant adenoviruses induce more efficient antitumor immunity than dendritic cells pulsed with peptide. Vaccine 2006;24:2860.
27. Hanke T, Schneider J, Gilbert SC, et al. DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: Immunogenicity in mice. Vaccine 1998;16:426.
28. + cytotoxic T-cells: Implications for vaccine design. Proc Natl Acad Sci USA 1995;92:5845.
29. Smith S, Patel P, Porte J, et al. Human dendritic cells genetically engineered to express a melanoma polyepitope DNA vaccine induce multiple cytotoxic T-cell responses. Clin Cancer Res 2001;7:4253.
30. +) cytotoxic T-cell epitopes. J Viro 1999;73:5320.